Evidence map›Paper›PMID 23730535›Full record

ArticleJournal of AIDS & clinical research2013

Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against

Shariq A Khan, Paul L Fidel, Awdah Al Thunayyan, Sharon Varlotta, Timothy F Meiller, Mary Ann Jabra-Rizk

Open access · hybridAbstract read
In one paragraph

Article in Journal of AIDS & clinical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Salivary proteins modulate Candida albicans virulence and may prevent oropharingeal candidiasis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Novel impacts of saliva with regard to oral health.The Journal of prosthetic dentistry · 2022
    Review
  8. Article
  9. Long-Term Post-COVID-19 Associated Oral Inflammatory Sequelae.Frontiers in cellular and infection microbiology · 2022
    Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Clinical Characteristics and Relevance of OralJournal of fungi (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Review
  18. Applying the Host-Microbe Damage Response Framework toJournal of fungi (Basel, Switzerland) · 2020
    Review
  19. Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis.Protein science : a publication of the Protein Society · 2020
    Article
  20. Oral Candidiasis: A Disease of Opportunity.Journal of fungi (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shariq A KhanDepartment of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, USA.
Paul L Fidel
Awdah Al Thunayyan
Sharon Varlotta
Timothy F Meiller
Mary Ann Jabra-Rizk
University of Maryland, Baltimore · US

Funding

Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MYERS, JEFFREY NICHOLAS · 2002 to 2012
$26.1M
Receptor Affects Fungal Mucosal Colonization in HIVR03DE016257 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI JABRA-RIZK, MARY ANN Y · 2004 to 2005
$149k
NCI NIH HHS P50 CA097007NIDCR NIH HHS R03 DE016257
6 · The paper itself

Abstract

HIV-infected individuals constitute a population highly susceptible to opportunistic infections, particularly oral candidiasis caused by the most pathogenic human fungal species

Indexed as

C. albicansHistatin-5HIV/AIDSInnate immunityOpportunistic infectionsOral candidiasisSalivary antimicrobial peptide

Identifiers

PMID23730535
PMCPMC3666036
OpenAlexW1530625518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.